Jefferies Financial Group initiated coverage on shares of USANA Health Sciences (NYSE:USNA) in a report released on Thursday morning, 24/7 WallStreet reports. The firm issued a hold rating and a $65.00 price objective on the stock.
USNA has been the subject of a number of other reports. TheStreet cut shares of USANA Health Sciences from a b- rating to a c+ rating in a report on Thursday, July 11th. ValuEngine upgraded shares of USANA Health Sciences from a sell rating to a hold rating in a report on Thursday, August 1st. Pivotal Research restated a buy rating on shares of USANA Health Sciences in a report on Wednesday, July 24th. Finally, Sidoti downgraded shares of USANA Health Sciences from a buy rating to a neutral rating and set a $70.00 price target for the company. in a research report on Wednesday, July 3rd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $70.00.
USANA Health Sciences stock opened at $64.29 on Thursday. The firm has a 50 day simple moving average of $64.96 and a 200-day simple moving average of $80.58. The stock has a market capitalization of $1.50 billion, a PE ratio of 12.46 and a beta of 0.44. USANA Health Sciences has a 12-month low of $58.30 and a 12-month high of $134.65.
Several large investors have recently modified their holdings of USNA. Tower Research Capital LLC TRC purchased a new stake in shares of USANA Health Sciences in the 2nd quarter valued at approximately $27,000. Royce & Associates LP lifted its position in USANA Health Sciences by 66.4% in the 1st quarter. Royce & Associates LP now owns 381 shares of the company’s stock worth $32,000 after buying an additional 152 shares in the last quarter. LS Investment Advisors LLC purchased a new stake in USANA Health Sciences in the 2nd quarter worth approximately $32,000. Advisory Services Network LLC purchased a new stake in USANA Health Sciences in the 2nd quarter worth approximately $65,000. Finally, NEXT Financial Group Inc purchased a new stake in USANA Health Sciences in the 2nd quarter worth approximately $79,000. Institutional investors and hedge funds own 66.39% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Read More: Gap Down Stocks
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.